Sale!

Oncomine Focus Panel

Original price was: $1,500.Current price is: $1,126.

-25%

The Oncomine Focus Panel is a cutting-edge next-generation sequencing (NGS) test that comprehensively analyzes 52 key cancer-related genes to identify specific genetic mutations driving tumor growth. This advanced molecular diagnostic test provides crucial information for personalized cancer treatment decisions by detecting actionable mutations, fusions, and copy number variations. The test requires tumor tissue samples and delivers results within 2-3 weeks, offering valuable insights for oncologists to select targeted therapies and immunotherapies. Available for $1126 USD (regularly $1500), this comprehensive panel helps guide precision oncology approaches for various cancer types including lung, breast, colorectal, and melanoma cancers.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Oncomine Focus Panel: Comprehensive Cancer Genetic Testing

Understanding the Oncomine Focus Panel

The Oncomine Focus Panel represents a revolutionary advancement in cancer diagnostics, utilizing next-generation sequencing (NGS) technology to provide comprehensive genetic profiling of tumor tissue. This sophisticated molecular test analyzes 52 carefully selected cancer-related genes that are clinically relevant for treatment decision-making in oncology practice.

As precision medicine continues to transform cancer care, the Oncomine Focus Panel serves as a critical tool for oncologists seeking to identify specific genetic alterations driving tumor growth. By providing detailed molecular information, this test enables healthcare providers to move beyond traditional one-size-fits-all treatment approaches and instead develop personalized therapeutic strategies based on the unique genetic profile of each patient’s cancer.

What the Oncomine Focus Panel Measures

The Oncomine Focus Panel employs advanced NGS technology to detect multiple types of genetic alterations across 52 key cancer genes:

  • Single Nucleotide Variants (SNVs): Identifies point mutations that can activate oncogenes or inactivate tumor suppressor genes
  • Insertions and Deletions (Indels): Detects small insertions or deletions that can disrupt gene function
  • Gene Fusions: Identifies chromosomal rearrangements that create fusion genes with oncogenic potential
  • Copy Number Variations (CNVs): Detects gene amplifications or deletions that can drive cancer progression

This comprehensive approach ensures that multiple potential therapeutic targets are evaluated simultaneously, providing a complete picture of the molecular landscape of the tumor.

Who Should Consider the Oncomine Focus Panel

The Oncomine Focus Panel is particularly beneficial for patients with:

  • Advanced or metastatic solid tumors requiring targeted therapy options
  • Cancers with limited treatment responses to conventional therapies
  • Rare cancer types where standard treatment guidelines are limited
  • Patients seeking clinical trial eligibility based on molecular biomarkers
  • Individuals with family history of cancer seeking comprehensive tumor profiling
  • Patients with recurrent or progressive disease requiring new treatment strategies

Clinical Benefits of Oncomine Focus Panel Testing

Undergoing the Oncomine Focus Panel offers numerous advantages for cancer patients and their healthcare teams:

  • Personalized Treatment Selection: Identifies specific targeted therapies matched to genetic alterations
  • Comprehensive Biomarker Analysis: Evaluates multiple biomarkers simultaneously from a single tissue sample
  • Clinical Trial Matching: Helps identify eligibility for precision medicine clinical trials
  • Treatment Resistance Insights: Provides information about potential resistance mechanisms
  • Minimized Tissue Usage: Maximizes information obtained from limited tumor tissue samples
  • Evidence-Based Decision Making: Supports treatment decisions with robust molecular data

Understanding Your Test Results

Your Oncomine Focus Panel results will provide detailed information about the genetic alterations detected in your tumor sample:

  • Actionable Mutations: Genetic changes with approved targeted therapies available
  • Investigational Targets: Alterations that may qualify you for clinical trials
  • Prognostic Markers: Genetic features that provide information about disease course
  • Therapeutic Recommendations: Specific drug suggestions based on detected alterations

Your oncologist will review the comprehensive report with you, explaining the clinical significance of each finding and discussing how the results may influence your treatment plan. The report typically includes information about FDA-approved therapies, clinical trial options, and relevant scientific literature supporting the findings.

Test Pricing and Availability

Test Name Discount Price Regular Price
Oncomine Focus Panel $1126 USD $1500 USD

Nationwide Testing Availability

GGC DNA provides comprehensive Oncomine Focus Panel testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our network of certified laboratories ensures consistent, high-quality testing regardless of your location.

Book Your Oncomine Focus Panel Test Today

Take the next step in your cancer care journey with comprehensive genetic profiling. Our experienced genetic counselors and oncology specialists are available to discuss how the Oncomine Focus Panel can benefit your treatment plan. Contact us today to schedule your test or learn more about our precision oncology services.

Call or WhatsApp: +1(267) 388-9828

Note: The Oncomine Focus Panel requires a doctor’s prescription and is performed using paraffin-embedded tumor tissue blocks. Prescription requirements do not apply to surgical cases, pregnancy-related testing, or individuals planning international travel. Results are typically available within 2-3 weeks from sample receipt.